Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // January 10th, 2012 // 7:55 am
Hello, everyone, and how are you today? A cold, but sunny day is emerging over the Pharmalot corporate campus, where we are hustling the short people off to their respective schoolhouses. The usual rush-rush. You have your own reasons to scurry about, of course, but please pause for a moment to fortify yourself with a cup of stimulation. Meanwhile, here are some tidbits to jumpstart the day. Hope it goes well and you conquer the world…
WebMD Scraps Talks And Warns Of A Weak Year (Reuters)
Genentech Signs $646M Pact With Xenon For Pain Drugs (Pharma Times)
Boehringer’s Pradaxa Increases Heart Attack Risk: Study (Bloomberg News)
Eighth Retraction Marks Erosion Of Lung Cancer Research (Reuters)
Statins Cost Four Times More In US Than UK (Modern Medicine)
Charles River Labs May Be For Sale (Outsourcing Pharma)
Glaxo Wants To Sell Other OTC Meds ASAP (Bloomberg News)
Abbott To Sell Apricus Topical Impotence Drug In Canada (Reuters)
Human Genome Lupus Drug Misses Forecasts (Dow Jones)
Americans Cut Back On Healthcare During Recession (CNBC)
Merck Vows To Be A Leader In Hepatitis C Treatments (Bloomberg News)
Regeneron Eye Drug Exceeds Sales Forecasts In First Month (Bloomberg News)
Lilly CEO Sees Threats From European Debt, Japan Price Cuts (Dow Jones)
Nicotine Patches Will Not Help Smokers In The Long Run (USA Today)
EDITOR’S NOTE: Please check this post for updates throughout the morning
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Abbott Laboratories, Apricus Biosciences, Boehringer Ingelheim, Bristol Myers Squibb, Canada, Charles River Laboratories, Cholesterol, Eli Lilly, Erectile Dysfunction, European Debt Crisis, Genentech, GlaxoSmithKline, Healthcare, Hepatitis C, Human Genome Sciences, Impotence, Inhibitex, JAMA, Japan, Journal of the American Medical Association, Lupus, Medical Journals, Medical Research, Merck, Nicotine, Nicotine Patches, OTC, Over The Counter, Pradaxa, Recession, Regeneron Pharmaceuticals, Retractions, Roche, Statins, UK, United States, US, Vertex Pharmaceuticals, WebMD, Xenon